Serum capacity to neutralize superantigens does not affect the outcome of Staphylococcus aureus bacteremia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 8, 2012, Pages 2061-2068

  Yi, J ^a   Park, J S ^b   Hong, K H ^b   Lee, S H ^b   Kim, E C ^b,c  

^a Pusan National University School of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; SUPERANTIGEN;

ADULT; ARTICLE; BACTERIUM ISOLATION; BLOOD ANALYSIS; CATHETER INFECTION; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GENE; HUMAN; HUMAN CELL; INTRAVASCULAR CATHETER; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SEC GENE; SEL GENE; SEP GENE; SERODIAGNOSIS; SIMPLIFIED ACUTE PHYSIOLOGY SCORE II; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; SUPERNATANT; SURVIVAL TIME; T LYMPHOCYTE; TST GENE; UNIVERSITY HOSPITAL;

EID: 84866391369     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1541-2     Document Type: Article

References (30)

1. Eykyn SJ, Gransden WR, Phillips I (1990) The causative organisms of septicaemia and their epidemiology. J Antimicrob Chemother 25(Suppl C):41-58 (Pubitemid 20158919)
2. Kim SH, Park WB, Lee KD, Kang CI, Kim HB, Oh MD, Kim EC, Choe KW (2003) Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin Infect Dis 37:794-799
3. Guilarde AO, Turchi MD, Martelli CM, Primo MG (2006) Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital. J Hosp Infect 63:330-336 (Pubitemid 43812197)
4. Soriano A, Martínez JA, Mensa J, Marco F, Almela M, Moreno- Martínez A, Sánchez F, Muñoz I, Jiménez de Anta MT, Soriano E (2000) Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 30:368-373 (Pubitemid 30131548)
5. Holtfreter S, Bröker BM (2005) Staphylococcal superantigens: do they play a role in sepsis? Arch Immunol Ther Exp (Warsz) 53:13- 27 (Pubitemid 40364722)
6. Llewelyn M, Cohen J (2002) Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis 2:156-162 (Pubitemid 34462450)
7. Ono HK, Omoe K, Imanishi K, Iwakabe Y, Hu DL, Kato H, Saito N, Nakane A, Uchiyama T, Shinagawa K (2008) Identification and characterization of two novel staphylococcal enterotoxins, types S and T. Infect Immun 76:4999-5005
8. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA (2004) Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364:703-705 (Pubitemid 39140626)
9. Holtfreter S, Roschack K, Eichler P, Eske K, Holtfreter B, Kohler C, Engelmann S, Hecker M, Greinacher A, Bröker BM (2006) Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J Infect Dis 193: 1275-1278
10. Darenberg J, Ihendyane N, Sjölin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A; StreptIg Study Group (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebocontrolled trial. Clin Infect Dis 37:333-340 (Pubitemid 36976489)
11. Lappin E, Ferguson AJ (2009) Gram-positive toxic shock syndromes. Lancet Infect Dis 9:281-290
12. Nilsson IM, Verdrengh M, Ulrich RG, Bavari S, Tarkowski A (1999) Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J Infect Dis 180:1370-1373 (Pubitemid 30070231)
13. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ESICM/ACCP/ ATS/SIS (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250-1256
14. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963 (Pubitemid 24000804)
15. Harbarth S, Rutschmann O, Sudre P, Pittet D (1998) Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 158:182-189 (Pubitemid 28049512)
16. Mylotte JM, Tayara A (2000) Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 31:1170-1174 (Pubitemid 32295446)
17. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG (1992) CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 13:606-608
18. Hwang SY, Kim SH, Jang EJ, Kwon NH, Park YK, Koo HC, Jung WK, Kim JM, Park YH (2007) Novel multiplex PCR for the detection of the Staphylococcus aureus superantigen and its application to raw meat isolates in Korea. Int J Food Microbiol 117:99-105 (Pubitemid 46726676)
19. Holtfreter S, Bauer K, Thomas D, Feig C, Lorenz V, Roschack K, Friebe E, Selleng K, Lövenich S, Greve T, Greinacher A, Panzig B, Engelmann S, Lina G, Bröker BM (2004) egc-Encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin. Infect Immun 72:4061-4071 (Pubitemid 38821921)
20. Horita N, Yokota S, Fuse S, Takamuro M, Tomita H, Sato K, Fujii N, Tsutsumi H (2004) The throat flora and its mitogenic activity in patients with Kawasaki disease. Microbiol Immunol 48:899-903 (Pubitemid 39602048)
21. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554 (Pubitemid 36437931)
22. Fowler VG Jr, Justice A, Moore C, Benjamin DK Jr, Woods CW, Campbell S, Reller LB, Corey GR, Day NP, Peacock SJ (2005) Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 40:695-703 (Pubitemid 40381343)
23. Desachy A, Lina G, Vignon P, Hashemzadeh A, Denis F, Etienne J, Francois B, Ploy MC (2007) Role of superantigenic strains in the prognosis of community-acquired methicillinsusceptible Staphylococcus aureus bacteraemia. Clin Microbiol Infect 13:1131-1133 (Pubitemid 47543116)
24. O'Donnell S, Humphreys H, Hughes D (2008) Distribution of virulence genes among colonising and invasive isolates of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 14:625-626 (Pubitemid 351639084)
25. Price J, Baker G, Heath I, Walker-Bone K, Cubbon M, Curtis S, Enright MC, Lindsay J, Paul J, Llewelyn M (2010) Clinical and microbiological determinants of outcome in Staphylococcus aureus bacteraemia. Int J Microbiol 2010:654858
26. Ferry T, Thomas D, Genestier AL, Bes M, Lina G, Vandenesch F, Etienne J (2005) Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin Infect Dis 41:771-777 (Pubitemid 41266740)
27. Holtfreter S, Grumann D, Schmudde M, Nguyen HT, Eichler P, Strommenger B, Kopron K, Kolata J, Giedrys-Kalemba S, Steinmetz I, Witte W, Bröker BM (2007) Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J Clin Microbiol 45:2669-2680 (Pubitemid 47295502)
28. Derzelle S, Dilasser F, DuquenneM, Deperrois V (2009) Differential temporal expression of the staphylococcal enterotoxins genes during cell growth. Food Microbiol 26:896-904
29. Grumann D, Scharf SS, Holtfreter S, Kohler C, Steil L, Engelmann S, Hecker M, Völker U, Bröker BM (2008) Immune cell activation by enterotoxin gene cluster (egc)-encoded and nonegc superantigens from Staphylococcus aureus. J Immunol 181: 5054-5061
30. Fraser JD, Proft T (2008) The bacterial superantigen and superantigen-like proteins. Immunol Rev 225:226-243